Clinical Trials on Prosthetic Treatment in South Africa
Total 572 results
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Sophiris Bio CorpCompletedBenign Prostatic HyperplasiaUnited States, Australia, Canada, Russian Federation, Ukraine, New Zealand
-
Duke UniversityCompleted
-
ACADIA Pharmaceuticals Inc.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States
-
Myriad Genetic Laboratories, Inc.Carolina Urologic Research CenterCompleted
-
PfizerCompletedProstatic NeoplasmsUnited States
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Centocor Research & Development, Inc.CompletedProstate CancerUnited States, United Kingdom, Belgium, Russian Federation
-
Bristol-Myers SquibbCompleted
-
Dana-Farber Cancer InstituteBayer; Decipher BiosciencesRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Threshold PharmaceuticalsTerminatedBenign Prostatic HyperplasiaUnited States
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
MDx HealthTerminatedProstate CancerUnited States
-
Eli Lilly and CompanyCompletedBenign Prostatic Hyperplasia (BPH)Italy, France, Belgium, Australia, Greece, Austria, Netherlands, Germany, Mexico, Poland
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Bristol-Myers SquibbCompletedProstatic NeoplasmsUnited States, Argentina, Czech Republic, India, Italy, Korea, Republic of, Mexico, Poland, Spain, Sweden, Germany, Australia, Canada, Peru, Russian Federation, Hungary, Ireland, South Africa, France, Brazil, Romania, United Kingdom, Finla... and more
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
BlueWind MedicalRecruitingTreatment of Patients Suffering From Overactive Bladder (OAB)United States, Belgium, Netherlands, United Kingdom
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Invitae CorporationCompleted
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Novo Nordisk A/STerminated
-
PfizerCompletedMigraine | Acute Treatment of MigraineUnited States
-
AmgenRecruitingProstate CancerJapan, United States, Korea, Republic of, Taiwan, Australia, Spain, Germany, Switzerland, Portugal, China
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
Daniel George, MDJanssen Scientific Affairs, LLCActive, not recruiting
-
Vaccitech (UK) LimitedRecruiting
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedFatigue | Cancer Survivor | Sleep Disorders | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Watson PharmaceuticalsCompletedBenign Prostatic HyperplasiaUnited States
-
Exosome Diagnostics, Inc.Completed
-
GlaxoSmithKlineCompletedProstatic HyperplasiaGermany, Australia, Netherlands, Spain, Hungary, France, Greece
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
Watson PharmaceuticalsCompletedBenign Prostatic Hyperplasia (BPH)United States
-
Bavarian NordicNational Cancer Institute (NCI); Therion Biologics CorporationCompletedProstate CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer...CompletedProstate CancerUnited States
-
Clarity Pharmaceuticals LtdCompletedBiochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine